360 related articles for article (PubMed ID: 9288551)
1. Complementary insulin therapy improves blood glucose and serum lipid parameters in type 2 (non-insulin-dependent) diabetic patients. II. Effects on serum lipids, lipoproteins and apoproteins.
Vaverková H; Chlup R; Ficker L; Novotny D; Bartek J
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():74-7. PubMed ID: 9288551
[TBL] [Abstract][Full Text] [Related]
2. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
Chow CC; Tsang LW; Sorensen JP; Cockram CS
Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472
[TBL] [Abstract][Full Text] [Related]
3. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS
Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227
[TBL] [Abstract][Full Text] [Related]
4. Comparison of different insulin regimens in elderly patients with NIDDM.
Wolffenbuttel BH; Sels JP; Rondas-Colbers GJ; Menheere PP; Nieuwenhuijzen Kruseman AC
Diabetes Care; 1996 Dec; 19(12):1326-32. PubMed ID: 8941458
[TBL] [Abstract][Full Text] [Related]
5. Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group.
Kumar S; Boulton AJ; Beck-Nielsen H; Berthezene F; Muggeo M; Persson B; Spinas GA; Donoghue S; Lettis S; Stewart-Long P
Diabetologia; 1996 Jun; 39(6):701-9. PubMed ID: 8781766
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study.
Chappuis B; Braun M; Stettler C; Allemann S; Diem P; Lumb PJ; Wierzbicki AS; James R; Christ ER
Diabetes Metab Res Rev; 2007 Jul; 23(5):392-9. PubMed ID: 17211855
[TBL] [Abstract][Full Text] [Related]
7. Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control.
Chang CJ; Kao JT; Wu TJ; Lu FH; Tai TY
Diabetes Care; 1995 Aug; 18(8):1191-4. PubMed ID: 7587858
[TBL] [Abstract][Full Text] [Related]
8. Effect of intensive glycemic control on fibrinogen, lipids, and lipoproteins: Veterans Affairs Cooperative Study in Type II Diabetes Mellitus.
Emanuele N; Azad N; Abraira C; Henderson W; Colwell J; Levin S; Nuttall F; Comstock J; Sawin C; Silbert C; Marcovina S; Lee HS
Arch Intern Med; 1998 Dec 7-21; 158(22):2485-90. PubMed ID: 9855387
[TBL] [Abstract][Full Text] [Related]
9. Insulin and sulfonylurea therapy in NIDDM patients. Are the effects on lipoprotein metabolism different even with similar blood glucose control?
Romano G; Patti L; Innelli F; Di Marino L; Annuzzi G; Iavicoli M; Coronel GA; Riccardi G; Rivellese AA
Diabetes; 1997 Oct; 46(10):1601-6. PubMed ID: 9313756
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein lipids and apolipoproteins (AI, AII, B, CII, CIII) in type 1 and type 2 diabetes mellitus in young Kuwaiti women.
al-Muhtaseb N; al-Yusef AR; Bajaj JS
Diabet Med; 1991 Oct; 8(8):732-7. PubMed ID: 1838064
[TBL] [Abstract][Full Text] [Related]
11. Lipid and lipoprotein patterns in type 2 non-obese diabetic patients. Do Lp(a) levels decrease with improved glycemic control in these patients?
Alagözlü H; Gültekin F; Candan F
Nutr Metab Cardiovasc Dis; 2000 Aug; 10(4):204-8. PubMed ID: 11079258
[TBL] [Abstract][Full Text] [Related]
12. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus.
Rosenblatt S; Miskin B; Glazer NB; Prince MJ; Robertson KE;
Coron Artery Dis; 2001 Aug; 12(5):413-23. PubMed ID: 11491207
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein abnormalities in well-treated type II diabetic patients.
Manzato E; Zambon A; Lapolla A; Zambon S; Braghetto L; Crepaldi G; Fedele D
Diabetes Care; 1993 Feb; 16(2):469-75. PubMed ID: 8432219
[TBL] [Abstract][Full Text] [Related]
14. Improved blood glucose control by insulin therapy in type 2 diabetic patients has no effect on lipoprotein(a) levels.
Wolffenbuttel BH; Leurs PB; Sels JP; Rondas-Colbers GJ; Menheere PP; Nieuwenhuijzen Kruseman AC
Diabet Med; 1993 Jun; 10(5):427-30. PubMed ID: 8334821
[TBL] [Abstract][Full Text] [Related]
15. Effect of pravastatin on serum lipids, apolipoproteins and lipoprotein (a) in patients with non-insulin dependent diabetes mellitus.
Umeda F; Watanabe J; Inoue K; Hisatomi A; Mimura K; Yamauchi T; Sako Y; Kunisaki M; Tajiri Y; Nawata H
Endocrinol Jpn; 1992 Feb; 39(1):45-50. PubMed ID: 1535040
[TBL] [Abstract][Full Text] [Related]
16. Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.
Rubies-Prat J; Ordóñez-Llanos J; Martin S; Blanco-Vaca F; Molina L; Goday A; Pedro-Botet J
Clin Exp Hypertens; 2001 Aug; 23(6):489-500. PubMed ID: 11478431
[TBL] [Abstract][Full Text] [Related]
17. Lipoproteins and apolipoproteins in young nonobese Arab women with NIDDM treated with insulin.
Al-Muhtaseb N; Al-Yusuf AR; Abdella N; Fenech F
Diabetes Care; 1989 May; 12(5):325-31. PubMed ID: 2656141
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein subfraction composition in non-obese newly diagnosed non-insulin dependent diabetes after treatment with diet and glibenclamide.
Billingham MS; Milles JJ; Bailey CJ; Hall RA
Diabetes Res; 1989 May; 11(1):13-20. PubMed ID: 2515931
[TBL] [Abstract][Full Text] [Related]
19. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
[TBL] [Abstract][Full Text] [Related]
20. The use of low glycaemic index foods improves metabolic control of diabetic patients over five weeks.
Fontvieille AM; Rizkalla SW; Penfornis A; Acosta M; Bornet FR; Slama G
Diabet Med; 1992 Jun; 9(5):444-50. PubMed ID: 1611832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
